MediWound (MDWD) Cash & Equivalents (2013 - 2025)

MediWound's Cash & Equivalents history runs 13 years deep, the most recent figure standing at $4.8 million for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 47.58% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $4.8 million (down 47.58% YoY), while the FY2025 annual figure was $4.8 million, down 47.58% from the prior year.
• Cash & Equivalents was $4.8 million for Q4 2025 at MediWound, down from $59.1 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $59.1 million in Q3 2025 to a low of $1.1 million in Q2 2025.
• Historically, Cash & Equivalents has averaged $23.0 million across 5 years, with a median of $15.8 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents jumped 243.55% in 2023, then slumped 91.08% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $11.0 million in 2021, then surged by 206.85% to $33.9 million in 2022, then sank by 64.99% to $11.9 million in 2023, then dropped by 22.85% to $9.2 million in 2024, then tumbled by 47.58% to $4.8 million in 2025.
• The last three Cash & Equivalents figures came in at $4.8 million (Q4 2025), $59.1 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.